ACP
NITE

Acuta Capital Partners’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Acuta Capital Partners’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100,000
Closed -$1.92M – 94
2017
Q3 		$1.92M Buy
+100,000
New +$2.16M 0.34% 42

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acuta Capital Partners's NITE Position: Q4 2017 in Review

Acuta Capital Partners sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 100,000 shares — an estimated $1.92M sold.

Acuta Capital Partners first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $1.92M in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • Acuta Capital Partners reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Acuta Capital Partners sold 100,000 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $1.92M.
  • Acuta Capital Partners first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Acuta Capital Partners's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.92M in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on Acuta Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.